FDA panel endorses Johnson & Johnson ketamine nasal spray for treatment-resistant depression.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA discourages people against 'young blood' infusions, which make unproven claims to reverse agingThe FDA is advising against 'young blood' infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Consulte Mais informação »
FDA warns against using young blood as medical treatmentThe US Food and Drug Administration warned against using plasma infusions from young blood donors to ward off the effects of normal aging as well as other more serious conditions.
Consulte Mais informação »
'Young blood' treatments to stop aging, disease are a 'significant public health concern': FDA
Consulte Mais informação »
'Young blood' company Ambrosia halts patient treatments after FDA warningThe FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
Consulte Mais informação »